Skin conditions (dermatitis, eczema, psoriasis) decisions — 2023

The Veteran's seborrheic dermatitis is rated at 30 percent effective May 26, 2020. The condition covers more than 20 to 40 percent of the entire body or exposed areas.

The Board has remanded the claims for service connection for eczema/sarcoidosis of the skin, pulmonary condition (sarcoidosis of the lungs), and lumbar spine condition due to inadequate medical opinions and failure to reconcile the Veteran's testimony at his hearing.

The Board has remanded the claim for an increased rating for onychomycosis with tinea pedis due to issues regarding pain and flare-ups, as well as distinguishing between the Veteran's service-connected conditions.

The Veteran's seborrheic dermatitis is being remanded for a new examination to assess the current severity of his condition, as the previous VA examiner did not fully examine all areas affected by the skin disorder.

The Veteran's hypertension is granted a 10% rating, but no higher, throughout the claim period.,Service connection for a skin condition other than chest keloid scars (pseudofolliculitis barbae) is denied.

The Veteran's claims for psoriasis and joint pains (claimed as in hands and hips) have been reopened, with the latter condition also granted. The low back disability claim is remanded.

The Board denied service connection for a skin rash, tinea cruris, and neurofibroma as the evidence did not support an in-service event or link to service.

The Board has decided to remand the Veteran's claims for pseudofolliculitis barbae and bilateral hearing loss due to inadequate examinations, and requests additional evidence and evaluations.

The Board has decided to remand the claim for service connection of a skin disorder due to the need for an adequate medical examination and opinion.

The Veteran's skin disability, including tinea cruris and tinea corporis, has not been rated appropriately. The Board finds that a remand is necessary to provide the Veteran with an opportunity for a VA examination to determine the severity of his service-connected skin disabilities.

The Veteran's skin condition is remanded for further evaluation and a VA examination to determine the nature and etiology of his skin disorder(s). The examiner must assume that he was exposed to herbicide agents during service.

The Veteran's appeal includes multiple issues related to his service-connected conditions and new claims. The Board has determined that these matters are inextricably intertwined with the previously adjudicated issues, and thus must be remanded for further consideration.

The Veteran's bilateral pes planus with degenerative arthritis, scars of the left ankle and knee, and skin condition (eczema) have been granted initial ratings. The Veteran is now rated at 50% for his bilateral pes planus.

The Veteran's appeal for service connection for tinea versicolor has been dismissed because the Veteran and his attorney have withdrawn the appeal.

The Board has dismissed all claims as the Veteran withdrew his appeals prior to a decision being made.

The Board has remanded the Veteran's claims for additional medical opinions to determine the etiology of his right hip, right leg, and skin rash conditions. The issues are related to service connection.

The Veteran's initial compensable rating for psoriasis prior to July 24, 2013 was denied. A rating in excess of 10 percent for psoriasis since July 24, 2013 is also denied.

The Veteran's appeals for pseudofolliculitis barbae, right pelvic bone disorder, and neck disorder have been dismissed.,The Veteran's claim for service connection for a bilateral hand disorder has been reopened due to new evidence submitted since the August 2014 rating decision.

The Board has remanded the case for a new VA examination to determine the nature and etiology of the Veteran's skin disability, specifically eczema. The Veteran is seeking service connection for this condition.

The Veteran's service connection claim for dermatitis is granted. An initial rating of 50 percent for social anxiety disorder prior to October 1, 2020, is also granted.